CD274 and glioblastoma: This study suggests that PD-L1 and VEGFR1 signaling pathways on TAMs may play a synergistic role in the regulation of tumor microenvironment, which is conducive to better understanding of the role of the combination of ICIs and anti-angiogenesis therapies in the regulation of antitumor immunity of GBM.